The COAPT study can be applied to a real-world mitral transcatheter edge-to-edge repair (M-TEER) population with similar results as trial participants, a new registry study concluded. 

Delivery of the Allegra transcatheter aortic bioprosthetic valve using the new Imperia fully repositionable delivery system had low rates of valve dysfunction, no valve failure and sustained hemodynamic performance at 1-year follow up in aortic stenosis (AS) patients in the EMPIRE I study. 

The first-ever guidelines for the management of cardiovascular-kidney-metabolic (CKM) syndrome suggest clinicians help patients maintain a healthy weight, assess patients for cardiovascular and kidney risk factors and understand the balance between cardiovascular and metabolic health. 

King and I | S7 E1 | Politics of Federal Funding Cuts

Early transcatheter aortic valve replacement (TAVR) may benefit asymptomatic patients with severe aortic stenosis (AS) across age groups from 65 years onward, a new analysis of the EARLY TAVR trial suggests. 

Patients with myocarditis can have atrial impairment in addition to left ventricular (LV) involvement and, in turn, additional risk for major adverse cardiovascular events (MACE), a new imaging study shows. 

Long-term survival after mitral valve surgery is similar between women and men once age and procedural differences are accounted for, although recurrent mitral regurgitation (MR) remains more common in women, a new meta-analysis suggests. 

The use of aspirin as a secondary prevention method for cardiovascular disease (CVD) remains stable despite negative messaging in the media, a new cross-sectional analysis shows. 

A coronary artery calcium (CAC) score of zero creates a low absolute risk of atherosclerotic cardiovascular disease (ASCVD) events over 15 years even in people with elevated lipoprotein(a) [Lp(a)], according to an analysis that supports the continued use of calcium scoring.